中前 美佳, 日野 雅之
　経口鉄剤内服後24時間の鉄吸収低下

中根孝彦、日野雅之
　KLF-1変異による多彩な貧血症状

中前博久
　GVL(graft versus leukemia)効果のメカニズム

中前博久
　PostCY大量療法を用いたハプロ移植

Miyamura K, Miyamoto T, Tanimoto M, Yamamoto K, Kimura S, Kawaguchi T, Matsumura I, Hata T, Tsurumi H, Saito S, Hino M, Tadokoro S, Meguro K, Hyodo H, Yamamoto M, Kubo K, Tsukada J, Kondo M, Aoki M, Okada H, Yanada M, Ohyashiki K, Taniwaki M.
　Switching to nilotinib in patients with chronic myeloid leukemia in chronic phase with molecular suboptimal response to frontline imatinib: SENSOR final results and BIM polymorphism substudy.

Nagasaki J, Aoyama Y, Hino M, Ido K, Ichihara H, Manabe M, Ohta T, Mugitani A.
　Wilms Tumor 1 (WT1) mRNA Expression Level at Diagnosis Is a Significant Prognostic Marker in Elderly Patients with Myelodysplastic Syndrome.

Kasashima H, Yashiro M, Nakamae H, Kitayama K, Masuda G, Kinoshita H, Fukuoka T, Hasegawa T, Nakane T, Hino M, Hirakawa K, Ohira M.
　CXCL1-Chemokine (C-X-C Motif) Receptor 2 Signaling Stimulates the Recruitment of Bone Marrow-Derived Mesenchymal Cells into Diffuse-Type Gastric Cancer Stroma.

Takagi S, Masuoka K, Uchida N, Kurokawa M, Nakamae H, Imada K, Iwato K, Ichinohe T, Atsuta Y, Takami A, Yano S
　Allogeneic Hematopoietic Cell Transplantation for Leukemic Transformation Preceded by Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: a Nationwide Survey by the Adult Aml Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT).

Maeda Y, Nishimori H, Inamoto Y, Nakamae H, Sawa M, Mori Y, Ohashi K, Fujiwara SI, Tanimoto M..
　Outcome differences between children and adolescents and young adults with non-Hodgkin lymphoma following stem cell transplantation.

Konuma T, Miyazaki Y, Uchida N, Ohashi K, Kondo T, Nakamae H, Takahashi S, Mori T, Ozawa Y, Kato C, Iwato K, Fukuda T, Ichinohe T, Atsuta Y, Ishiyama K; Adult Myelodysplastic Syndrome Working Group of the Japan Society for Hematopoietic Cell Transplantation
　Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Myelodysplastic Syndrome Harboring Trisomy 8.

Koh H, Aimoto M, Matsuhisa A, Inoue SI, Katayama T, Okamura H, Yoshimura T, Koh S, Nanno S, Nishimoto M, Nakashima Y, Hirose A, Nakamae M, Nakane T, Hino M, Nakamae H
　Combinational approach using in situ hybridization targeting 23S ribosomal RNA genes and blood cultures for bacterial identification in patients with neutropenia and fever.

小杉　智、柴山浩彦、中谷英仁、木田　亨、太田健介、金子仁臣、八木秀男、田中宏和、淵田真一、中谷　綾、小林正行、黒田純也、上辻由里、魚嶋伸彦、足立陽子、通堂　満、島崎千尋、野村昌作、日野雅之、松村　到、谷脇雅史、金倉　譲、高折晃史
　骨髄腫関連疾患における二次癌の検討　関西骨髄腫フォーラムデータベースを用いた解析

Koh S, Koh H, Nakashima Y, Katayama T, Sakabe M, Okamura H, Yoshimura T, Nanno S, Nishimoto M, Hayashi Y, Nakane T, Nakamae H, Ohsawa M, Hino M
　Plasma Kinetics of Th1, Th2 and Th17 Cytokines in Polymyositis Related to Chronic Graft-versus-Host Disease.

Nanno S, Koh H, Katayama T, Hashiba M, Sato A, Makuuchi Y, Nagasaki J, Kuno M, Yoshimura T, Okamura H, Nishimoto M, Hirose A, Nakamae M, Nakane T, Hino M, Nakamae H.
　Plasma Levels of Presepsin (Soluble CD14-subtype) as a Novel Prognostic Marker for Hemophagocytic Syndrome in Hematological Malignancies

康　秀男、日野雅之
　Waldenstroemマクログロブリン血症細胞の起源と進展

中前博久
　移植後大量シクロホスファミドを用いた血縁者間HLAハプロ一致移植

Takeoka Y, Sakatoku K, Miura A, Yamamura R, Araki T, Seura H, Okamura T, Koh H, Nakamae H, Hino M, Ohta K
　Prognostic Effect of Low Subcutaneous Adipose Tissue on Survival Outcome in Patients With Multiple Myeloma..

Yoshida C, Nakamae H, Fletcher L, Koga D, Sogabe T, Matsumura I, Kanakura Y, Branford S, Naoe T.
　Validation of a rapid one-step high sensitivity real-time quantitative PCR system for detecting major BCR-ABL1 mRNA on an International Scale.

Nanno S, Nakane T, Okamura H, Nishimoto M, Koh H, Nakamae H, Ohsawa M, Yarita K, Kamei K, Hino M.
　Disseminated Hormographiella aspergillata infection with involvement of the lung, brain, and small intestine following allogeneic hematopoietic stem cell transplantation: case report and literature review.

Koh H, Aimoto M, Katayama T, Hashiba M, Sato A, Kuno M, Makuuchi Y, Takakuwa T, Okamura H, Hirose A, Nakamae M, Hino M, Nakamae H
　Diagnostic value of levels of presepsin (soluble CD14-subtype) in febrile neutropenia in patients with hematological disorders.

Verstovsek S, Vannucchi AM, Griesshammer M, Masszi T, Durrant S, Passamonti F, Harrison CN, Pane F, Zachee P, Kirito K, Besses C, Hino M, Moiraghi B, Miller CB, Cazzola M, Rosti V, Blau I, Mesa R, Jones MM, Zhen H, Li J, Francillard N, Habr D, Kiladjian JJ
　Ruxolitinib versus best available therapy in patients with Polycythemia Vera: 80 Week follow up from the RESPONSE trial.

Yasuda T, Tsuzuki S, Kawazu M, Hayakawa F, Kojima S, Ueno T, Imoto N, Kohsaka S, Kunita A, Doi K, Sakura T, Yujiri T, Kondo E, Fujimaki K, Ueda Y, Aoyama Y, Ohtake S, Takita J, Sai E, Taniwaki M, Kurokawa M, Morishita S, Fukayama M, Kiyoi H, Miyazaki Y, Naoe T, Mano H
　Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults.

Nakamae M, Yamashita M, Koh H, Nishimoto M, Hayashi Y, Nakane T, Nakashima Y, Hirose A, Hino M, Nakamae H
　Lung function score including a parameter of small airway disease as a highly predictive indicator of survival after allogeneic hematopoietic cell transplantation

Hochhaus A, Saglio G, Hughes TP, Larson RA, Kim DW, Issaragrisil S, le Coutre PD, Etienne G, Dorlhiac-Llacer PE, Clark RE, Flinn IW, Nakamae H, Donohue B, Deng W, Dalal D, Menssen HD, Kantarjian HM
　Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial

Fuji S, Kim SW, Yano S, Hagiwara S, Nakamae H, Hidaka M, Ito T, Ohashi K, Hatanaka K, Takami A, Kurosawa S, Yamashita T, Yamaguchi T, Fukuda T.
　A prospective multicenter study of unrelated bone marrow transplants using a reduced-intensity conditioning regimen with low-dose ATG-F

Nagasaki J, Manabe M, Ido K, Ichihara H, Aoyama Y, Ohta T, Furukawa Y, Mugitani A
　Postinfluenza vaccination idiopathic thrombocytopenic purpura in three elderly patients

Nishiwaki S, Imai K, Mizuta S, Kanamori H, Ohashi K, Fukuda T, Onishi Y, Takahashi S, Uchida N, Eto T, Nakamae H, Yujiri T, Mori S, Nagamura-Inoue T, Suzuki R, Atsuta Y, Tanaka J.
　Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: a study from the adult ALL WG of the JSHCT.

Arai Y, Kanda J, Nakasone H, Kondo T, Uchida N, Fukuda T, Ohashi K, Kaida K, Iwato K, Eto T, Kanda Y, Nakamae H, Nagamura-Inoue T, Morishima Y, Hirokawa M, Atsuta Y, Murata M
　Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation.

Yoshida M, Nakao T, Horiuchi M, Ueda H, Hagihara K, Kanashima H, Inoue T, Sakamoto E, Hirai M, Koh H, Nakane T, Hino M, Yamane T
　Analysis of elderly patients with diffuse large B-cell lymphoma: Aggressive therapy is a reasonable approach for "unfit" patients classified by comprehensive geriatric assessment

Nakata-Yamada K, Inoue M, Ioka A, Ito Y, Tabuchi T, Miyashiro I, Masaie H, Ishikawa J, Hino M, Tsukuma H; and the Osaka Cancer Association for Children, Adolescents and Young Adults.
　Comparison of survival of adolescents and young adults with hematologic malignancies in Osaka, Japan

中前博久
　慢性骨髄性白血病

日野雅之
　急性骨髄性白血病

58th ASH (American Society of Hematology)

Safety and Efficacy of a Switch to Nilotinib in Patients with CML-CP Showing MMR to Imatinib: Results of a Multicenter Phase II Trial (NILSw Trial)
Shibayama H, Kawaguchi T, Kuroda J, Nakamae H, Matsumura I, Miyamoto T, Ishikawa J, Kamimura T, Fukushima K, Imamura Y, Eto T, Sunami K, Shimokawa M, Akashi K, Kanakura Y

第78回日本血液学会

PL-3
Crinical features and prognosis of unselected patients with AML and RAEB-2: JALSG CS07 studyMiyazaki Y, Sakura T, Yanada M, Takase K, Imai K, Dobashi N, Aoyama Y, Sawa M, Itonaga H, Usuki K,Honda S, Ohtake S, Kiyoi H, Ohnishi K, Kobayashi Y, Naoe T